Loading data for ANIP — first visit, this takes a few seconds.
ANI Pharmaceuticals Inc. (ANIP)
NasdaqGM: ANIP
· Real-Time Price · USD
72.83
-0.68 (-0.93%)
At close: Aug 28, 2026, 8:00 PM
72.83
+0.00%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
ANI Pharmaceuticals Inc. (ANIP) Stock Price, Analysis & Data
-0.93% (1D)
No data available
| Bid | 56.91 |
| Market Cap | 1.67B |
| Revenue (ttm) | 978.38M |
| Net Income (ttm) | 99.6M |
| 0.46 | |
| 4.54 | |
| 16.04 | |
| 6.98 | |
| P/B (ttm) | 2.61 |
| P/S (ttm) | 1.71 |
| Earnings Date | Nov 6, 2026 |
| Ask | 103.53 |
| Volume | 360,969 |
| Avg. Volume (20D) | 342,531 |
| Open | 73.23 |
| Previous Close | 73.51 |
| Day's Range | 72.61 - 73.93 |
| 52-Week Range | 70.15 - 99.50 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ANIP
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to nat...
Full Company ProfileFinancial Performance
In 2025, ANI Pharmaceuticals's revenue was 883.37M, an increase of 43.78% compared to the previous year's 614.38M. Earnings were 78.34M, a decrease of -522.94%.
Financial StatementsEarnings Surprise
ANI Pharmaceuticals has released their quarterly earnings on Aug 7, 2026:
- Revenue of $266.04M misses estimates by $0, with 25.87% YoY growth.
- EPS of 2.21 exceeds estimates by 0.17, with 22.78% YoY growth.
ANI Pharmaceuticals Inc. is scheduled to release its earnings on Nov 6, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2